To learn about the connection of the VEGFA enhancer to its alternative splicing, we used the CML cell line, K562, mutated at the VEGFA enhancer using the CRISPR/Cas9 genome-editing system. This evidence concerns the gene VEGFA and chronic myelogenous leukemia, BCR-ABL1 positive.